Portal de investigación
nab-paclitaxel/carboplatin (nab-P/C) induction therapy in squamous (SCC) non-small cell lung cancer (NSCLC): Interim safety results from ABOUND.sqm
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Gridelli, C
- McCleod, M
- Morgensztern, D
- Daniel, DB
- Page, R
- Wehler, T
- Levy, B
- Ardizzoni, A
- Berry, T
- Chen, T
- Trunova, N
- Jotte, R
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Gridelli,C,McCleod,M,Morgensztern,D,Daniel,DB,Page,R,Wehler,T,Juan,O et al. nab-paclitaxel/carboplatin (nab-P/C) induction therapy in squamous (SCC) non-small cell lung cancer (NSCLC): Interim safety results from ABOUND.sqm. 42nd European-Society-for-Medical-Oncology Congress (ESMO). 2017. Madrid. RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS:ELSEVIER. 2017.